Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation

Area of Science:

• Urology
• Oncology
• Clinical Chemistry

Background:

• Prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) are biomarkers used in prostate cancer management.
• Understanding the diurnal variation of these markers is crucial for accurate interpretation of test results.

Purpose of the Study:

• To investigate the daily variation of serum PSA and PAP levels in patients with prostate cancer, benign prostatic hyperplasia, and healthy volunteers.
• To determine if circadian rhythms or other patterns influence PSA and PAP levels throughout the day.

Main Methods:

• Simultaneous measurement of serum PSA and PAP levels at 8 AM, 12 PM, 4 PM, and 8 PM.
• Inclusion of 10 patients with metastatic prostate cancer, 10 with benign prostatic hyperplasia, and 10 healthy volunteers.
• Statistical analysis using two-factor analysis of variance to assess diurnal patterns and differences between disease groups.

Main Results:

• No evidence of circadian rhythmic variation or distinct patterns in PSA or PAP levels was observed across the sampling times.
• Serum PSA levels exhibited significantly less variability compared to serum PAP levels.
• No significant differences in the mean percent variation of PSA and PAP were found between the patient groups.

Conclusions:

• Serum PSA and PAP levels fluctuate unpredictably throughout the day in individuals with and without prostate disease.
• The greater variability of PAP compared to PSA suggests potential limitations in its use for monitoring.
• Single measurements of serum PSA or PAP may be inaccurate for tracking disease recurrence and treatment response in prostate cancer patients.